Stephen Henry took home the prize of Supreme Innovator award at the NZ Innovators Awards.
His company Kode Biotech have created a cancer treatment using the human body’s own auto immune responses.
The treatment involves injecting cells that mimic toxic animal tissue into tumours.
As the immune system naturally rejects animal tissue, it attacks the tumour.
In June the company signed a licensing agreement with UK company Agalimmune that could be worth up to $47 million.
Kode Biotech also took home the award for Best Innovation in Health and Science.